Gabriel M - Search Results

1

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss.

Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. Moschen AR, et al. Among authors: gabriel m. Gut. 2005 Apr;54(4):479-87. doi: 10.1136/gut.2004.044370. Gut. 2005. PMID: 15753532 Free PMC article.

2

Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas.

Ensinger C, Spizzo G, Moser P, Tschoerner I, Prommegger R, Gabriel M, Mikuz G, Schmid KW. Ensinger C, et al. Among authors: gabriel m. Ann N Y Acad Sci. 2004 Dec;1030:69-77. doi: 10.1196/annals.1329.009. Ann N Y Acad Sci. 2004. PMID: 15659782

3

An individual dosimetric approach to 153Sm-EDTMP therapy for pain palliation in bone metastases in correlation with clinical results.

Kendler D, Donnemiller E, Oberladstätter M, Erler H, Gabriel M, Riccabona G. Kendler D, et al. Among authors: gabriel m. Nucl Med Commun. 2004 Apr;25(4):367-73. doi: 10.1097/00006231-200404000-00009. Nucl Med Commun. 2004. PMID: 15097811

4

99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.

Gabriel M, Froehlich F, Decristoforo C, Ensinger C, Donnemiller E, von Guggenberg E, Heute D, Moncayo R. Gabriel M, et al. Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):330-41. doi: 10.1007/s00259-003-1376-x. Epub 2003 Nov 19. Eur J Nucl Med Mol Imaging. 2004. PMID: 14625664 Clinical Trial.

5

Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe 1-Tyr 3-octreotide and chromogranin A assay in patients with neuroendocrine tumours.

Rodrigues M, Gabriel M, Heute D, Putzer D, Griesmacher A, Virgolini I. Rodrigues M, et al. Among authors: gabriel m. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1796-802. doi: 10.1007/s00259-008-0794-1. Epub 2008 Apr 19. Eur J Nucl Med Mol Imaging. 2008. PMID: 18425512

6

Increased F-18 fluorodeoxyglucose accumulation in a benign neurofibroma--a pitfall in a patient with thyroid cancer: a case report.

Gabriel M, Erler H, Donnemiller E, Riccabona G. Gabriel M, et al. Nuklearmedizin. 2002 Apr;41(2):N14-5. Nuklearmedizin. 2002. PMID: 11989305 No abstract available.

7

An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.

Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R. Gabriel M, et al. J Nucl Med. 2003 May;44(5):708-16. J Nucl Med. 2003. PMID: 12732671 Free article.

8

Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas.

Ensinger C, Prommegger R, Kendler D, Gabriel M, Spizzo G, Mikuz G, Kremser R. Ensinger C, et al. Among authors: gabriel m. Anticancer Res. 2003 May-Jun;23(3B):2241-3. Anticancer Res. 2003. PMID: 12894498

9

Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.

Ensinger C, Prommegger R, Kendler D, Gabriel M, Spizzo G, Mikuz G, Kremser R. Ensinger C, et al. Among authors: gabriel m. Anticancer Res. 2003 May-Jun;23(3B):2349-53. Anticancer Res. 2003. PMID: 12894514

10

CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism.

Profanter C, Wetscher GJ, Gabriel M, Sauper T, Rieger M, Kovacs P, Bale R, Prommegger R. Profanter C, et al. Among authors: gabriel m. Surgery. 2004 Feb;135(2):157-62. doi: 10.1016/s0039-6060(03)00396-9. Surgery. 2004. PMID: 14739850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

906 results

Search Page

Filters